Clinical Trial Update: A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on CPV-104 evaluating safety, tolerability, and pharmacokinetics in healthy adults and individuals with C3 glomerulopathy; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy

Drugs mentioned

• CPV-104

Snippet

Sponsor: eleva GmbH | Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants | Phase 1 | Status: RECRUITING